BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1654837)

  • 1. Free radical scavenging is involved in the protective effect of L-propionyl-carnitine against ischemia-reperfusion injury of the heart.
    Packer L; Valenza M; Serbinova E; Starke-Reed P; Frost K; Kagan V
    Arch Biochem Biophys; 1991 Aug; 288(2):533-7. PubMed ID: 1654837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: the possible role of iron chelation.
    Reznick AZ; Kagan VE; Ramsey R; Tsuchiya M; Khwaja S; Serbinova EA; Packer L
    Arch Biochem Biophys; 1992 Aug; 296(2):394-401. PubMed ID: 1321584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of L-carnitine and its acetyl and propionyl esters on ATP and PCr levels of isolated rat hearts perfused without fatty acids and investigated by means of 31P-NMR spectroscopy.
    Löster H; Keller T; Grommisch J; Gründer W
    Mol Cell Biochem; 1999 Oct; 200(1-2):93-102. PubMed ID: 10569188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria.
    Ferrari R; Ceconi C; Cargnoni A; Pasini E; Boffa GM; Curello S; Visioli O
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():57-65. PubMed ID: 2031872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect of L-carnitine on ischemia-reperfusion heart.
    Xie J; Zeng Q; Wang L
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(2):188-91. PubMed ID: 16850743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective activity of the spin trap tert-butyl-alpha-phenyl nitrone (PBN) in reperfused rat heart.
    Bradamante S; Monti E; Paracchini L; Lazzarini E; Piccinini F
    J Mol Cell Cardiol; 1992 Apr; 24(4):375-86. PubMed ID: 1619668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propionyl-L-carnitine prevents renal function deterioration due to ischemia/reperfusion.
    Mister M; Noris M; Szymczuk J; Azzollini N; Aiello S; Abbate M; Trochimowicz L; Gagliardini E; Arduini A; Perico N; Remuzzi G
    Kidney Int; 2002 Mar; 61(3):1064-78. PubMed ID: 11849462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcium antagonists and free radical scavengers on myocardial ischemia and reperfusion injury: evaluation by 31P-NMR spectroscopy.
    Ohsuzu F; Yanagida S; Sakata N; Nakamura H
    Jpn Circ J; 1989 Sep; 53(9):1138-43. PubMed ID: 2601005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of propionyl-L-carnitine during ischemia and reperfusion.
    Shug A; Paulson D; Subramanian R; Regitz V
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():77-83. PubMed ID: 2031875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of the reperfused heart by L-propionylcarnitine.
    Leipälä JA; Bhatnagar R; Pineda E; Najibi S; Massoumi K; Packer L
    J Appl Physiol (1985); 1991 Oct; 71(4):1518-22. PubMed ID: 1757378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of dimethyl amiloride against postischemic myocardial dysfunction in rabbit hearts: phosphorus 31-nuclear magnetic resonance measurements of intracellular pH and cellular energy.
    Koike A; Akita T; Hotta Y; Takeya K; Kodama I; Murase M; Abe T; Toyama J
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):765-75. PubMed ID: 8800166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of the specific endothelin-1 antagonist BQ610 on mechanical function and energy metabolism during ischemia/reperfusion injury in isolated perfused rat hearts.
    Illing B; Horn M; Han H; Hahn S; Bureik P; Ertl G; Neubauer S
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):487-94. PubMed ID: 8847864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting effects of propionate and propionyl-L-carnitine on energy-linked processes in ischemic hearts.
    Di Lisa F; Menabò R; Barbato R; Siliprandi N
    Am J Physiol; 1994 Aug; 267(2 Pt 2):H455-61. PubMed ID: 8067396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
    Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
    Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of protection of PBN in isolated heart during ischemia and reperfusion: implications for radical scavenging mechanism.
    Baker JE; Konorev EA; Tse SY; Joseph J; Kalyanaraman B
    Free Radic Res; 1994 Mar; 20(3):145-63. PubMed ID: 8019639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the superoxide radical scavenger superoxide dismutase, and of the hydroxyl radical scavenger mannitol, on reperfusion injury in isolated rabbit hearts.
    Ambrosio G; Flaherty JT
    Cardiovasc Drugs Ther; 1992 Dec; 6(6):623-32. PubMed ID: 1337978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scavenging effect of Chinonin on NO and oxygen free radicals and its protective effect on the myocardium from the injury of ischemia-reperfusion.
    Zhao B; Shen J; Li M; Li M; Wan Q; Xin W
    Biochim Biophys Acta; 1996 Mar; 1315(2):131-7. PubMed ID: 8608170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective action of iron-chelating agents (catechol, mimosine, deferoxamine, and kojic acid) against ischemia-reperfusion injury of isolated neonatal rabbit hearts.
    Katoh S; Toyama J; Kodama I; Kamiya K; Akita T; Abe T
    Eur Surg Res; 1992; 24(6):349-55. PubMed ID: 1338045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acylcarnitine accumulation does not correlate with reperfusion recovery in palmitate-perfused rat hearts.
    Madden MC; Wołkowicz PE; Pohost GM; McMillin JB; Pike MM
    Am J Physiol; 1995 Jun; 268(6 Pt 2):H2505-12. PubMed ID: 7611501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.